D.E. Shaw & Co’s Adient ADNT Stock Holding History

D.E. Shaw & Co’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,900	Closed	-$257K	–	4210
2024 Q4	$257K	Sell	14,900 -10,100	-40%	-$202K	﹤0.01%	3972
2024 Q3	$564K	Buy	+25,000	New	+$572K	﹤0.01%	3631
2020 Q1	–	Sell	-25,600	Closed	-$544K	–	3883
2019 Q4	$544K	Sell	25,600 -16,700	-39%	-$370K	﹤0.01%	3347
2019 Q3	$971K	Sell	42,300 -23,600	-36%	-$538K	﹤0.01%	2848
2019 Q2	$1.6M	Sell	65,900 -9,300	-12%	-$191K	﹤0.01%	2391
2019 Q1	$975K	Buy	75,200 +19,600	+35%	+$343K	﹤0.01%	2621
2018 Q4	$837K	Sell	55,600 -93,900	-63%	-$2.43M	﹤0.01%	2785
2018 Q3	$5.88M	Buy	149,500 +130,200	+675%	+$5.87M	0.01%	1477
2018 Q2	$949K	Buy	+19,300	New	+$1.1M	﹤0.01%	2731
2018 Q1	–	Sell	-11,900	Closed	-$937K	–	3449
2017 Q4	$937K	Buy	+11,900	New	+$960K	﹤0.01%	2618

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

D.E. Shaw & Co's ADNT Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Adient (ADNT) stake by 4.5% in Q1 2026, selling an estimated $3.41M and leaving 3,283,218 shares worth $66.4M. The position accounts for 0.04% of the portfolio, ranked #541.

D.E. Shaw & Co first reported a position in ADNT in Q4 2016 and has held it in 31 quarters since. The position peaked at $74.9M in Q3 2025. 286 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

D.E. Shaw & Co held 3,283,218 shares of Adient worth $66.4M as of Q1 2026.
D.E. Shaw & Co sold 153,365 Adient shares in Q1 2026, an estimated $3.41M.
Adient made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #541 holding.
D.E. Shaw & Co first reported a position in Adient in Q4 2016 and has held it in 31 quarters since.
D.E. Shaw & Co's Adient position peaked at $74.9M in Q3 2025.
286 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.